Whitehawk Therapeutics, Inc. (WHWK) Free cash flow 2016–2025
Whitehawk Therapeutics, Inc. (WHWK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$98.0MFY2025 · since FY2016: -$137,814 → -$98.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.0M | -60.1% |
| FY2024 | -$61.2M | +3.8% |
| FY2023 | -$63.6M | -27.1% |
| FY2022 | -$50.1M | -122.9% |
| FY2021 | -$22.5M | -76.6% |
| FY2020 | -$12.7M | +47.2% |
| FY2019 | -$24.1M | -312.1% |
| FY2018 | -$5.8M | +69.1% |
| FY2017 | -$18.9M | -13608.6% |
| FY2016 | -$137,814 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice